A drug cocktail that prevents neuronal degeneration in Alzheimer's disease

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		UML 01-14
IP Type:		Licensable Technology
Title:		A drug cocktail that prevents neuronal degeneration in Alzheimer's disease
Inventor:		Thomas Shea
Summary:		The cocktail is an inexpensive, patent-pending, over-the-counter formulation consisting entirely of vitamins and nutraceuticals, which clinical trials have demonstrated to prevent cognitive decline in aging, and even shown improvement in both long term and short memory of healthy adults with no signs of Alzheimer’s disease.
Tech Type:		Therapeutics-Drugs
URL:		http://www.uml.edu/cvip
Contact:		Susu Wong, 978 934 4722, susu_wong@uml.edu
Organization:		University of Massachusetts Lowell

Display all intellectual properties for Thomas Shea
Display all intellectual properties for University of Massachusetts Lowell